Research ArticleSpastin subcellular localization is regulated through usage of different translation start sites and active export from the nucleus
Introduction
Hereditary spastic paraplegia (HSP) is a neurodegenerative disorder, characterized by weakness and spasticity of the lower limbs [1], [2]. These symptoms arise as a consequence of the degeneration of the axons of the corticospinal tracts, which convey voluntary motor impulses from pyramidal neurons in the motor cortex to spinal motor neurons [3]. Albeit genetically heterogeneous, most cases of HSP are inherited as an autosomal dominant trait and are due to mutations in the SPG4 gene, encoding spastin, a 616 amino acid molecule belonging to the AAA family of ATPases [4], [5], [6]. This family is characterized by the AAA domain, often located in the C-terminal part of the protein, and comprises a vast number of molecules residing in different cellular compartments that use ATP hydrolysis to drive very diverse biological functions [7], [8]. AAA proteins can be regarded as molecular machines involved in the disassembly of protein complexes. The specific function of a single AAA protein is often determined by its binding to molecular targets through their N-terminal region [9].
The function of spastin and its role in the pathogenesis of HSP are being actively investigated in different biological systems. Previous studies performed in our laboratory suggested a role of spastin in microtubule dynamics [10]. We showed that the microtubule network in cells expressing a considerable amount of spastin is disrupted, suggesting that spastin might be implicated in microtubule severing, as demonstrated for the highly homologous p60 katanin. Spastin microtubule severing activity has been recently confirmed using both the human and Drosophila recombinant proteins [11], [12]. Overexpressed spastin interacts with the microtubules through its N-terminal region, and this interaction is regulated through the ATPase activity of the AAA domain, such that mutants in the AAA domain display a stable association with the cytoskeleton, while wild-type spastin is likely to be rapidly released from microtubules upon ATP hydrolysis [10]. More recently, we studied spastin subcellular localization and found that spastin is enriched in cellular regions characterized by extensive remodeling of the cytoskeleton [13]. During cell division spastin is a component of the centrosome, where it interacts with the centrosomal protein NA14. In postmitotic motor neurons in vitro, spastin is enriched in the growth cones and in the branching regions [13], two sites of high dynamic events involving microtubules. Independent studies have also found spastin in the cytoplasm and synaptic terminals of pyramidal cells of the cerebral cortex and hippocampus, in Purkinje cells, and in spinal motor neurons [14].
A confirmation to the possible role of spastin in regulating the microtubule network comes from studies in Drosophila melanogaster. In this system, spastin overexpression induces a decrease of microtubule stability and strength at synaptic junctions [15], [16]. Strikingly, loss-of-function mutant larvae display a phenotype in the neuromuscular junction, with more numerous synaptic boutons and impaired neurotransmitter release, associated with fewer microtubule bundles [16]. As adults, spastin-null flies have severe movement defects [16]. These data strongly suggest that spastin may modulate synaptic strength and function, by acting as a regulator of microtubule stability.
Another line of investigation has identified a possible role of spastin in intracellular membrane trafficking. This role is linked to the presence in spastin of the MIT domain that interacts with CHMP1B, a protein associated with the ESCRT (endosomal sorting complex required for transport)-III complex [17]. This complex is involved in targeting membrane-associated cargoes to multivesicular bodies, but the exact role of CHMP1B in this process is still unknown. Notably, the MIT domain is common to a group of proteins involved in endocytosis and trafficking, such as SKD1, and SNX15 [18], and is also present in spartin, the product of the SPG20 gene, mutations in which cause a complicated autosomal recessive form of HSP, Troyer syndrome [19].
Although all the functional data obtained to date point to roles of spastin in the cytoplasm, there is convincing evidence that spastin is also a nuclear protein. Spastin contains three predicted nuclear signals, two of which were experimentally validated [20]. Spastin nuclear localization in different cell types was detected by us and by others using different antibodies [13], [14], [21]. This notwithstanding, when spastin is overexpressed in vitro the vast majority of the protein is always found in the cytoplasm [10], [17], [22]. We now provide evidence that targeting of spastin to the nucleus or the cytoplasm is regulated through two mechanisms, the usage of alternative translational start sites and active nuclear export to the cytoplasm. These data contribute to recognize spastin as a polymorph protein, with a possible array of functions in both the nucleus and the cytoplasm.
Section snippets
Antibodies and reagents
The S51 antibody has been previously reported [13]. Monoclonal anti β-tubulin antibody (Sigma) was used 1:2500. Monoclonal anti-histone H1 antibody (Santa Cruz) was used 1:100. DAPI was purchased by Roche. Leptomycin B (LMB) was a kind gift from Dr. Minoru Yoshida (RIKEN Institute, Japan).
Constructs
To generate the spastinCDS construct, the full-length spastin coding sequence was amplified with appropriate primers and subcloned into the pcDNA3 vector (BamHI/NotI). This clone was subsequently modified to
Spastin is targeted both to the nucleus and the cytoplasm when expressed by a construct containing 5′ UTR sequences
Endogenous spastin has a complex subcellular localization, nuclear and/or cytoplasmic, dependent on the cell type. However, when overexpressed, spastin localizes mainly in cytoplasmic punctate structures. To address the apparent discrepancy between the cellular localization of endogenous and overexpressed spastin, we generated expression constructs that would mimic the endogenous situation. We cloned the SPG4 coding sequence into the pcDNA3 vector, either in the presence (spastin5UTR) or in the
Discussion
The subcellular localization of spastin has been a matter of debate, mainly due to discrepancies between the cytoplasmic targeting of overexpressed spastin and the detection of endogenous spastin in the nucleus of many, but not all, cell types [10], [13], [14], [21]. Although the proposed roles of spastin in microtubule dynamics and membrane trafficking are all linked to the presence of the protein in the cytoplasm, the possibility that spastin might perform a nuclear function has never been
Acknowledgments
We thank M. Yoshida for the generous gift of LMB, R. Ferrentino for technical assistance, and G. Meroni for helpful discussion. This work was supported by the Italian Telethon Foundation, the European Union (contract number LSHM-CT-2003-503382), and the Fondazione Mariani.
References (44)
- et al.
AAA+ proteins and substrate recognition, it all depends on their partner in crime
FEBS Lett.
(2002) - et al.
The Drosophila homologue of the hereditary spastic paraplegia protein, spastin, severs and disassembles microtubules
Curr. Biol.
(2005) - et al.
The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function
Curr. Biol.
(2004) - et al.
The identification of a conserved domain in both spartin and spastin, mutated in hereditary spastic paraplegia
Genomics
(2003) - et al.
Identification of nuclear localisation sequences in spastin (SPG4) using a novel Tetra-GFP reporter system
Biochem. Biophys. Res. Commun.
(2004) - et al.
CRM1 is an export receptor for leucine-rich nuclear export signals
Cell
(1997) - et al.
Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1
Exp. Cell Res.
(1998) - et al.
Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression
J. Biol. Chem.
(1994) - et al.
Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins
J. Biol. Chem.
(1997) - et al.
A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals
Exp. Cell Res.
(2000)
A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression
Cell
Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions
J. Struct. Biol.
Advances in the hereditary spastic paraplegias
Exp. Neurol.
Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias
J. Med. Genet.
Hereditary “pure” spastic paraplegia
Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia
Nat. Genet.
Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia
Hum. Mol. Genet.
Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis
J. Med. Genet.
An AAA family tree
J. Cell Sci.
The AAA team: related ATPases with diverse functions
Trends Cell Biol.
Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics
Hum. Mol. Genet.
Linking axonal degeneration to microtubule remodeling by spastin-mediated microtubule severing
J. Cell Biol.
Cited by (104)
Genetic architecture of motor neuron diseases
2022, Journal of the Neurological SciencesCitation Excerpt :The spastin protein produces different cellular isoforms as a result of alternative translation of start codons and differential splicing of exon 4. These isoforms comprise a full-length 68 kDa (616 amino acids) protein called M1, and a slightly shorter 60 kDa (530 amino acids) protein called M87, which lacks the first 86 amino acids (Fig. 9) [384,385] They both share all of the different domains, except for the N-terminus, which is solely expressed in the M1 subtype while absent in the M87. Prior studies revealed that in rodents and humans, the full-length M1 isoform is expressed at higher concentrations in spinal cord regions only, whereas the shorter M87 (M85 in rodents) isoform is expressed ubiquitously in both the spinal cord and cerebral cortex regions [386,387].
A newly identified NES sequence present in spastin regulates its subcellular localization and microtubule severing activity
2021, Biochimica et Biophysica Acta - Molecular Cell ResearchCitation Excerpt :Furthermore, the full-length spastin fused with the NLS of the SV40 large T antigen showed the cytoplasmic localization despite having two NLSs. Two of the three NES sequences fused with both nuclear protein Braf 35 (36 kDa) and GFP were localized in the cytoplasm, and accumulated in the nucleus after LMB treatment [17]. These results indicate that M1 has two active NES at its N-terminus.
Structure of spastin bound to a glutamate-rich peptide implies a hand-over-hand mechanism of substrate translocation
2020, Journal of Biological ChemistryCitation Excerpt :Human spastin is expressed from a single gene as four different isoforms (26). The full-length (M1) protein comprises 616 amino acid residues, whereas use of an alternative initiator methionine produces the more abundant M87 isoforms (27, 28). Alternative splicing of both M1 and M87 spastin produces two other isoforms that differ by the presence or absence of exon 4, which encodes residues 197–228 and lies between the MIT domain and the ATPase cassette (26).
Pluripotent Stem Cells as a Preclinical Cellular Model for Studying Hereditary Spastic Paraplegias
2024, International Journal of Molecular Sciences